84413-3-RR

antibody from Proteintech Group

Targeting: CCL20 CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

84413-3-RR

Provider

Proteintech Group

Product name

CCL20/MIP-3 alpha monoclonal antibody

Antibody type

Recombinant

Description

CCL20/MIP-3 alpha monoclonal antibody (Catalog no. 84413-3-RR) is a rabbit recombinant antibody that shows reactivity with human, mouse and has been validated for the following applications: WB, IHC, ELISA

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

241694B4

References

Submitted references

Tumor-Derived CXCL10 and CCL20 Polarize the Immune Microenvironment in Nasopharyngeal Carcinoma via Competitive Recruitment of Effector T Cells and Tregs.

Zhang B, Yuan X, Meng L, Liu Y, Wang Y, Chen Z, Zeng H, Zhang X, Peng Z, Zhang H, Jiang W
International journal of medical sciences 2026;23(1):26-41

---

Bie-Jia-Jian Pill: Inhibiting tumor glycolysis and promoting CD8(+) cell-mediated anti-tumor immunity by targeting HIF-1α-PI3K/AKT/mTOR and CCL20 in hepatocellular carcinoma.

Liu Y, Yang X, Qin M, Chen W, Liu C, Jiang W, Wang Y, Tan S, Sun H, Chen J, Sun H, He S
Journal of ethnopharmacology 2026 Jun 28;365:121554

---

Targeting HSPB1 inhibits tumor growth and abrogates Treg-mediated tumor immunosuppression.

Hu Q, Lu Y, Zhong X, Huang P, Zheng L, Jiang BH, Li W, Zheng SG
International immunopharmacology 2026 Apr 1;174:116333